Abercrombie & Fitch Co. Achieves Record U.S. Black Friday Week Revenues; Reaffirms Fourth Quarter Outlook
NEW ALBANY, Ohio, Jan. 13, 2020 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) today announced that it is […]
IGNITE International Brands to Focus on New Products and Distribution in 2020
VAUGHN, Ontario, Jan. 13, 2020 (GLOBE NEWSWIRE) — Ignite International Brands, Ltd. (CSE: BILZ; OTCQX: BILZF) (“IGNITE” or the “Company”) […]
VitalHub Continues Expansion of the B Care EHR Platform in the Province of Manitoba With a Sale to Eden Health Care Services
TORONTO, Jan. 13, 2020 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that […]
FTI Consulting Continues Investment in End-to-End Transactions Capabilities
Transactions Practice Unites Existing Expertise in a Single Go-to-Market, Industry-Focused ApproachScott Bingham Appointed Transactions Leader in the U.S.WASHINGTON, Jan. 13, […]
Sysco Announces Senior Leadership Changes to Accelerate Next Phase of Development
Kevin Hourican Elected as New President and Chief Executive OfficerEd Shirley Elected Executive ChairTom Bené to Step Down January 31, […]
Momenta Provides Year-End 2019 Update and 2020 Outlook
— Interim Phase 1 / 2 data of M254 in ITP supports expansion of lower dose cohorts; additional data expected […]
Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company […]
Tactile Systems Technology, Inc. Reports Preliminary Full Year and Fourth Quarter 2019 Revenue Results; Introduces Full Year 2020 Financial Outlook; Announces CEO Intends to Retire in 2020
MINNEAPOLIS, Jan. 13, 2020 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused […]
EUSA Pharma and BeiGene Announce Exclusive Development and Commercialization Agreement for SYLVANT® and QARZIBA®▼ in Greater China
– SYLVANT® and QARZIBA®▼ recently listed for fast-track approval in China –– Expands EUSA’s global product offering; broadens BeiGene’s portfolio […]
Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
Oncologie receives exclusive global license to develop and commercialize navicixizumabLONDON, and REDWOOD CITY, Calif., and BOSTON, Jan. 13, 2020 (GLOBE […]
